Charles River Laboratories Completes Acquisition of Galapagos’ CRO Services

News   Apr 03, 2014

 
Charles River Laboratories Completes Acquisition of Galapagos’ CRO Services
 
 
 

RELATED ARTICLES

Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes Synthesis

News

TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.

READ MORE

Cancer Fighting Compound Activated by Substance Found in Stinging Nettles

News

Researchers have developed a new line of attack against cancer: an organic-osmium compound, which is triggered using a non-toxic dose of sodium formate, a natural product found in many organisms, including nettles and ants.

READ MORE

Alzheimer’s Drug Discovery Foundation Announces $1.8M in New Funding

News

The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE